홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Acetonitrile → n-[4-[(3-Hydroxyphenyl)piperazine-1-yl]butyl]-3,4-dihydronaphtalene-2-carboxamide

HRID 254277
인쇄

반응식

HRID 254277 반응식
Br[CH2:2][CH2:3][CH2:4][CH2:5][NH:6][C:7]([CH:9]1[CH:18]=[CH:17][C:16]2[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=2)[CH2:10]1)=[O:8].[OH:19][C:20]1[CH:21]=[C:22](N2CCNCC2)[CH:23]=[CH:24][CH:25]=1.C([N:34]([CH2:37][CH3:38])[CH2:35][CH3:36])C.CC#[N:41]>>[OH:19][C:20]1[CH:21]=[C:22]([CH:35]2[CH2:36][NH:41][CH2:38][CH2:37][N:34]2[CH2:2][CH2:3][CH2:4][CH2:5][NH:6][C:7]([C:9]2[CH2:18][CH2:17][C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[CH:10]=2)=[O:8])[CH:23]=[CH:24][CH:25]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 4

HCID 6342AcetonitrileHCID 8471TriethylamineHCID 27365971-(3-Hydroxyphenyl)piperazineHCID 66852491n-(4-Bromobutyl)-dihydro-2-naphtylcarboxamide

생성물 1

HCID 23135106n-[4-[(3-Hydroxyphenyl)piperazine-1-yl]butyl]-3,4-dihydronaphtalene-2-carboxamide수율 54%

실험 절차

A mixture of the bromo adduct E1 (100 mg, 0.32 mmol), of commercial 3-hydroxyphenyl piperazine (57 mg, 0.32 mmol) and triethylamine (0.07 mL, 0.5 mmol) in CH3CN are reluxed during 16 h. The solvent is evaporated and the residue is taken up in CH2Cl2 (15 mL), washed with brine, dried and concentrated. The residue is purified by chromatography eluting with AcOEt:MeOH (9/1) to yield the titled adduct (mp 152° C., 70 mg, 54%)

후처리

  1. customThe solvent is evaporated
  2. washwashed with brine
  3. customdried
  4. concentrationconcentrated
  5. customThe residue is purified by chromatography
  6. washeluting with AcOEt

출처 및 근거

ORD 기록
ord-d5c811394752484d9f35c8383a6030e7
출처 데이터셋
uspto-grants-2011_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07875617B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트